Cargando…
How can we improve patients’ access to new drugs under uncertainties? : South Korea’s experience with risk sharing arrangements
BACKGROUND: New drugs including cancer drugs and orphan drugs are becoming increasingly more expensive. Risk sharing arrangements (RSAs) could manage the risk based on both financial impact and the health outcome of new drugs if reimbursed. To improve patients’ access to new drugs under uncertaintie...
Autores principales: | Lee, Boram, Bae, Eun-Young, Bae, SeungJin, Choi, Hyun-Jin, Son, Kyung-Bok, Lee, Young-Sil, Jang, Suhyun, Lee, Tae-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442279/ https://www.ncbi.nlm.nih.gov/pubmed/34521408 http://dx.doi.org/10.1186/s12913-021-06919-x |
Ejemplares similares
-
The Burden of Cervical Cancer in Korea: A Population-Based Study
por: Kim, Jinhee, et al.
Publicado: (2020) -
Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea
por: Choi, Inseon, et al.
Publicado: (2020) -
Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study
por: Son, Kyung-Bok, et al.
Publicado: (2019) -
How Sensitive is Sensitivity Analysis?: Evaluation of Pharmacoeconomic Submissions in Korea
por: Bae, SeungJin, et al.
Publicado: (2022) -
Marketing and Pricing Strategies of Blockbuster Drugs in the South Korean Market: A 15-Year Retrospective Cohort Study for Choline Alfoscerate
por: Park, Jeewon, et al.
Publicado: (2020)